or Try an Advanced Search...

    Blastoma Stocks List

    Symbol Grade Name % Change
    PRLD F Prelude Therapeutics Incorporated 0.86
    CLRB F Cellectar Biosciences, Inc. 0.32
    PSTV F Plus Therapeutics, Inc. 0.84
    TCON F TRACON Pharmaceuticals, Inc. -31.40
    AFMD F Affimed Therapeutics B.V. -2.56
    CNSP F CNS Pharmaceuticals, Inc. 4.53
    CRVO F CervoMed Inc. -0.83
    RGLS F Regulus Therapeutics Inc. 1.07
    YMAB F Y-mAbs Therapeutics, Inc. -3.51
    FENC F Fennec Pharmaceuticals Inc. 4.74
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Cancer Glioblastoma Biopharmaceutical Medicine Brain Tumor Oncology Clinical Development Disease Sarcoma Solid Tumors Cancer Treatment Carcinoma Chemotherapy Clinical Medicine Drugs Glioblastoma Multiforme Hepatocellular Carcinoma Lymphoma Macular Degeneration Neuroblastoma

    Related ETFs - A few ETFs which own one or more of the above listed Blastoma stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 5.74
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 3.9
    PJP D PowerShares Dynamic Pharmaceuticals 3.7
    FBT D First Trust Amex Biotech Index Fund 3.64
    GLRY B Inspire Faithward Mid Cap Momentum ESG ETF 3.33
    View all Blastoma ETFs...
    Compare ETFs
    Compare FTXH to PJP Compare PBE to PJP Compare PJP to GLRY

        Blastoma Stocks Recent News

        Date Stock Title
        Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
        Nov 19 CLRB Q3 2024 Cellectar Biosciences Inc Earnings Call
        Nov 18 CLRB Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript
        Nov 18 CNSP CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
        Nov 18 CLRB Cellectar Biosciences GAAP EPS of -$0.40 misses by $0.03
        Nov 18 CLRB Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
        Nov 18 CLRB Earnings Scheduled For November 18, 2024
        Nov 17 PSTV Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 PSTV Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
        Nov 15 CNSP CNS Pharmaceuticals reports Q3 results
        Nov 15 CNSP CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
        Nov 15 CLRB Cellectar Biosciences Q3 2024 Earnings Preview
        Nov 15 PSTV Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
        Nov 15 AFMD Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Cancer Glioblastoma Biopharmaceutical Biotechnology Brain Tumor Medicine Neuroblastoma Cancer Treatment Oncology Ovarian Cancer Acute Myeloid Leukemia Brain Cancer Cancer Center Cell Product Chemotherapy Clinical Medicine Diffuse Intrinsic Pontine Glioma Disease Genetics Glioma
        Blastoma

        A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated (or precursor) cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

        More about Blastoma
        Browse All Tags